Med Life Management
Management criteria checks 2/4
Med Life's CEO is Mihail Marcu, appointed in Dec 2016, has a tenure of 8.42 years. directly owns 14.78% of the company’s shares, worth €97.87M. The average tenure of the management team and the board of directors is 7.7 years and 8.4 years respectively.
Key information
Mihail Marcu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.4yrs |
| CEO ownership | 14.8% |
| Management average tenure | 7.7yrs |
| Board average tenure | 8.4yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Mihail Marcu (54 yo)
Mr. Mihail Marcu serves as Chief Executive Officer at S.C. Med Life S.A. since December 2016. Mr. Marcu served as the Chief Executive Officer of MedLife between January 2004 until August 2006 and vice pres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.4yrs | no data | 14.78% € 97.9m | |
| CFO & Investor Relations Manager | 2.6yrs | no data | no data | |
| Chief Healthcare & Operations Officer and Director | no data | no data | 10.42% € 69.0m | |
| Human Resources Director | 7.7yrs | no data | no data | |
| Deputy CEO | no data | no data | no data |
Experienced Management: O0C's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 18.8yrs | no data | 14.78% € 97.9m | |
| Chief Healthcare & Operations Officer and Director | 8.4yrs | no data | 10.42% € 69.0m | |
| Deputy CEO | 17.3yrs | no data | no data | |
| Independent Director | 4.4yrs | no data | no data | |
| Independent Director | 7.7yrs | no data | no data | |
| Director | 17.3yrs | no data | no data | |
| Independent Director | 4.4yrs | no data | no data |
Experienced Board: O0C's board of directors are considered experienced (8.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 23:42 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Med Life S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Caius Rapanu | Erste Group Bank AG |
| Marcin Nowak | Ipopema Securities S.A. |
| Catalin Diaconu | Raiffeisen Bank International AG - Institutional Equity |